Abstract
The secretion and metabolism of endogeneous neurotensin-like immunoreactivities after a test meal were studied in five healthy human subjects. Intact neurotensin and the N-terminal metabolic fragment, neurotensin 1–8, were quantified by radioimmunoassay with C- and N-terminally directed antisera in conjunction with gel filtration of plasma samples obtained at timed intervals. Both C- and N-terminal neurotensin-like immunoreactivities rose after the meal, reaching a plateau level after 20 and 30 min, respectively. During the plateau phase, which lasted for the rest of the experimental period of 180 min, the molar ratio of intact neurotensin to neurotensin 1–8 remained approximately constant at 1∶4.6. Meal-stimulated immunoreactive neurotensin appeared to be metabolized in a manner comparable to that of exogenously infused neurotensin in man. The results suggest that intact neurotensin is secreted at an approximately constant rate during the plateau phase. The relatively low plateau level of neurotensin 1–8, which has a much longer half-life than intact neurotensin in the circulation, implies that only a fraction of the secreted intact neurotensin is metabolized to neurotensin 1–8, indicating the existence of alternative pathways of neurotensin metabolism.
Similar content being viewed by others
References
Carraway R, Leeman SE: The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalamus. J Biol Chem 248:6854–6861, 1973
Carraway R, Leeman SE: The amino acid sequence of a hypothalamic peptide, neurotensin. J Biol Chem 250:1907–1911, 1975
Sundler F, Hakansson R, Hammer RA, Alumets, J, Carraway, R, Leeman SE, Zimmerman EA: Immunohistochemical localization of neurotensin in endocrine cells of the gut. Cell Tissue Res 178:313–321, 1977
Holzer P, Bucsics A, Saria A, Lembeck F: A study of the concentrations of substance P and neurotensin in the gastrointestinal tract of various mammals. Neurosciences 7:2919–2924, 1982
Polak JM, Sullivan SN, Bloom SR, Buchan AMJ, Facer P, Brown MR, Pearse AGE: Specific localization of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature 270:183–184, 1977
Hammer RA, Leeman SE, Carraway R, Williams RH: Isolation of human intestinal neurotensin. J Biol Chem 255:2476–2480, 1980
Ferri GL, Adrian TE, Ghatei MA, O'Shaughnesy DJ, Probert L, Lee YC, Buchan AMJ, Polak JM, Bloom SR: Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology 84:777–786, 1983
Blackburn AM, Fletcher DR, Bloom SR, Chritofides ND, Long RG, Fitzpatrick ML, Baron JH: Effect of neurotensin on gastric function in man. Lancet 1:987–989, 1980
Kihl B, Rokaeus A, Rosell S, Olbe L: Fat inhibition of gastric secretion in man and plasma concentration of neurotensin-like immunoreactivity. Scand J Gastroenterol 16:513–526, 1981
Thor K, Rokaeus A, Kager L, Rosell S: [Gln4]-Neurotensin and gastrointestinal motility in man. Acta Physiol Scand 110:327–328, 1980
Calam J, Unwin R, Peart WS: Neurotensin stimulates defecation. Lancet 1:737–738, 1983
Fletcher DR, Blackburn AM, Adrian TE, Chadwick VS, Bloom SR: Effect of neurotensin on pancreatic function in man. Life Sci 29:2157–2161, 1981
Blackburn AM, Fletcher DR, Adrian TE, Bloom SR: Neurotensin infusion in man: Pharmacokinetics and effect on gastrointestinal and pituitary hormones. J Clin Endocrinol Metab 51:1257–1261, 1980
Aronin N, Carraway RE, Ferris CF, Hammer RA, Leeman SE: The stability and metabolism of intravenously administered neurotensin in the rat. Peptides 3:637–642, 1982
Shulkes A, Fletcher DR, Hardy KJ: Organ and plasma metabolism of neurotensin in sheep. Am J Physiol 245:E457-E462, 1983
Lee YC, Allen JM, Uttenthal LO, Walker MC, Shemilt J, Gill SS, Bloom SR: The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma. J Clin Endocrinol Metab 59:45–50, 1984
Mashford ML, Nileson G, Rokaeus A, Rosell S: The effect of food ingestion on circulating neurotensin-like immunoreactivity (NTLI) in human. Acta Physiol Scand 104:244–246, 1978
Blackburn AM, Bloom SR: A radioimmunoassay for neurotensin in human plasma. J Endocrinol 83:175–181, 1979
Rosell S, Rokaeus A: The effect of ingestion of amino acids, glucose, and fat on circulating neurotensin-like immunoreactivity (NTLI) in man. Acta Physiol Scand 107:263–267, 1979
Go VLW, Demol P: Role of nutrients in the gastrointestinal release of immunoreactive neurotensin. Peptides 2(Suppl 2):267–269, 1981
Hammer RA, Carraway R, Leeman SE: Elevation of plasma neurotensin-like immunoreactivity after a meal. J Clin Invest 70:74–81, 1982
Shulkes A, Chick P, Wong H, Walsh JH: A radioimmunoassay for neurotensin in human plasma. Clin Chim Acta 125:49–58, 1982
Theodorsson-Norheim E, Rosell S: Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion. Regul Peptides 6:207–218, 1983
Carraway R, Leeman SE: Structure requirements for the biological activity of neurotensin, a new vasoactive peptide.In Peptides: Chemistry, Structure and Biology. R Walter, J Meinhofer (eds). Ann Arbor, Ann Arbor Press, 1975, pp. 679–685
Hammer RA, Leeman SE: Neurotensin: Properties and actions.In Gut Hormones. SR Bloom, JM Polak (eds). Edinburgh, Churchill Livingstone, 1981, pp. 290–311
Theodorsson-Norheim E, Oberg K, Rosell S, Bostrom H: Neurotensin immunoreactivity in plasma and tumor tissue from patients with endocrine tumors of the pancreas and gut. Gastroenterology 85:881–889, 1983
Hunter WM, Greenwood FC: Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194:495–496, 1962
Jorgensen KH, Larsen UD: Purification of125I-glucagon by an ion exchange chromatography. Horm Metab Res 4:223–224, 1972
Theodorsson-Norheim E: Evidence that (Gln4)-neurotensin is the naturally occurring neurotensin in plasma. Peptides 4:543–547, 1983
Wilk S, Orlowski M: Cation-sensitive neutral endopeptidase: Isolation and specificity of the bovine pituitary enzyme. J Neurochem 35:1172–1182, 1980
McDermot JR, Smith AI, Edwardson JA, Griffiths EC: Mechanism of neurotensin degradation by rat brain peptidases. Regul Peptides 3:397–404, 1982
Carraway R, Hammer RA, Leeman SE: Neurotensin in plasma: Immunochemical and chromatographic character of acid/acetone soluble material. Endocrinology 107:400–406, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, Y.C., Allen, J.M., Uttenthal, L.O. et al. Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal. Digest Dis Sci 30, 129–133 (1985). https://doi.org/10.1007/BF01308198
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01308198